381 studies found for:    Open Studies | "Mouth Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Mouth Diseases" (381 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in Vietnam
Condition: Hand Foot and Mouth Disease
Intervention:
2 Not yet recruiting Magnesium Sulphate for Severe Hand, Foot and Mouth Disease in Vietnam
Condition: Hand, Foot and Mouth Disease
Interventions: Drug: Magnesium Sulphate;   Drug: Sterile water
3 Unknown  A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Drug: Herbal concentrate-granules plus western therapy;   Drug: Reduning Injection plus western therapy;   Drug: Western therapy
4 Unknown  A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Other: Western therapy;   Other: Reduning Injection;   Other: Reduning Injection plus western therapy
5 Unknown  A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Other: Western therapy;   Drug: Xiyanping Injection;   Drug: Xiyanping Injection with western medicine
6 Recruiting Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder
Conditions: Burning Mouth Syndrome;   Taste Disorder;   Orofacial Pain
Intervention:
7 Not yet recruiting The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis
Condition: Peri-Implantitis
Intervention: Drug: 2.5 mg Chlorhexidine gluconate chip
8 Recruiting Polarized Reflectance Spectroscopy for Oral Lesions
Condition: Oral Cancer
Intervention: Device: Polarized Reflectance Spectroscopy System
9 Recruiting Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors
Conditions: Head and Neck Cancer;   Ototoxicity;   Radiation Toxicity
Interventions: Procedure: adjuvant therapy;   Procedure: assessment of therapy complications;   Procedure: quality-of-life assessment;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
10 Recruiting Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
Conditions: Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Chronic Myelogenous Leukemia;   Childhood Myelodysplastic Syndromes;   Chronic Eosinophilic Leukemia;   Chronic Myelomonocytic Leukemia;   Chronic Neutrophilic Leukemia;   de Novo Myelodysplastic Syndromes;   Disseminated Neuroblastoma;   Juvenile Myelomonocytic Leukemia;   Mucositis;   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Previously Treated Childhood Rhabdomyosarcoma;   Previously Treated Myelodysplastic Syndromes;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Relapsing Chronic Myelogenous Leukemia;   Secondary Acute Myeloid Leukemia;   Secondary Myelodysplastic Syndromes;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: supersaturated calcium phosphate rinse;   Other: placebo;   Other: questionnaire administration;   Procedure: quality-of-life assessment
11 Recruiting Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolysis
Intervention: Drug: Intravenous immunoglobulin
12 Recruiting Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery
Conditions: Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Stage I Squamous Cell Carcinoma of the Hypopharynx;   Stage I Squamous Cell Carcinoma of the Larynx;   Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage I Squamous Cell Carcinoma of the Oropharynx;   Stage I Verrucous Carcinoma of the Larynx;   Stage I Verrucous Carcinoma of the Oral Cavity;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Larynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Squamous Cell Carcinoma of the Oropharynx;   Stage II Verrucous Carcinoma of the Larynx;   Stage II Verrucous Carcinoma of the Oral Cavity;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Larynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer
Interventions: Drug: soy isoflavones;   Other: laboratory biomarker analysis;   Other: survey administration
13 Recruiting NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy
Condition: Xerostomia
Interventions: Drug: NeutraSal;   Drug: Placebo (for NeutraSal)
14 Unknown  Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus
Conditions: Atrophic Oral Lichen Planus;   Erosive Oral Lichen Planus
Interventions: Drug: placebo;   Drug: Quercetin
15 Recruiting Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity
Conditions: Xerostomia;   Depression;   Hypertension
Interventions: Drug: Malic Acid;   Other: Placebo
16 Not yet recruiting Efficacy of a Mouthwash Containing Propolis
Conditions: Gingivitis;   Periodontitis;   Plaque;   Inflammation
Interventions: Drug: Propolis;   Drug: chlorhexidine
17 Recruiting Development of a Milk Product Substitution for Patients Suffering From Xerostomia Caused by Medication
Condition: Xerostomia
Interventions: Other: LactoXeros;   Device: Aequasyal
18 Unknown  Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx
Condition: Head and Neck Cancer
Interventions: Biological: aldesleukin;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
19 Unknown  Botulinum Toxin to Improve Results in Cleft Lip Repair
Condition: Scar
Interventions: Drug: Botulinum Toxin Type A;   Drug: Botulinum Type A;   Drug: Normal Saline
20 Recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
Conditions: Rubella;   Mumps;   Measles
Interventions: Biological: Priorix®;   Biological: Merck's M-M-R®II, Measles, Mumps, and Rubella Virus Vaccine (also known as M-M-R Vax Pro™);   Biological: Kinrix®;   Biological: Varivax®

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years